[Controversies in the treatment of acute otitis media]

Elzbieta Hassmann-Poznańska1

  • 1Klinika Otolaryngologii Dzieciecej, Uniwersytetu Medycznego w Białymstoku. pedorl@umwb.edu.pl

Przeglad Lekarski
|May 14, 2011
PubMed

Insights

Acute otitis media (AOM), a common childhood illness, often leads to antibiotic overuse. This paper reviews AOM treatment, advocating for reduced antibiotic use due to pathogen resistance and spontaneous resolution, while outlining surgical options.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Otolaryngology

Context:

  • Acute otitis media (AOM) is a leading cause of antibiotic prescriptions in young children.
  • AOM presents a significant burden on healthcare systems, particularly in developing nations, due to potential complications.
  • Increasing antibiotic resistance in respiratory pathogens necessitates a re-evaluation of AOM treatment protocols.

Purpose:

  • To analyze the benefits and drawbacks of antibiotic therapy for acute otitis media.
  • To discuss the rationale for reducing antibiotic use in AOM management.
  • To present indications for surgical interventions in recurrent AOM cases.

Summary:

  • This paper examines the current landscape of AOM treatment, highlighting the frequent reliance on antibiotics.
  • It emphasizes the growing concern of antibiotic resistance and the natural course of AOM towards spontaneous resolution.
  • The review covers both conservative and surgical management strategies, including adenoidectomy and tympanostomy tube insertion for recurrent infections.

Impact:

  • Provides evidence-based insights for optimizing antibiotic stewardship in pediatric AOM.
  • Informs clinical decision-making regarding the judicious use of antibiotics versus watchful waiting.
  • Guides the selection of appropriate surgical interventions for children with recurrent AOM, potentially reducing disease burden.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...